ATE48945T1 - Antivirale zusammensetzungen. - Google Patents
Antivirale zusammensetzungen.Info
- Publication number
- ATE48945T1 ATE48945T1 AT84305102T AT84305102T ATE48945T1 AT E48945 T1 ATE48945 T1 AT E48945T1 AT 84305102 T AT84305102 T AT 84305102T AT 84305102 T AT84305102 T AT 84305102T AT E48945 T1 ATE48945 T1 AT E48945T1
- Authority
- AT
- Austria
- Prior art keywords
- antiviral compositions
- viral
- idoxuridine
- vidarabine
- acyclovir
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 abstract 1
- 229960004150 aciclovir Drugs 0.000 abstract 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229960004716 idoxuridine Drugs 0.000 abstract 1
- 229910003002 lithium salt Inorganic materials 0.000 abstract 1
- 159000000002 lithium salts Chemical class 0.000 abstract 1
- 229960003636 vidarabine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838320203A GB8320203D0 (en) | 1983-07-27 | 1983-07-27 | Anti-viral compositions |
| EP84305102A EP0135312B1 (de) | 1983-07-27 | 1984-07-26 | Antivirale Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE48945T1 true ATE48945T1 (de) | 1990-01-15 |
Family
ID=10546347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84305102T ATE48945T1 (de) | 1983-07-27 | 1984-07-26 | Antivirale zusammensetzungen. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US4886670A (de) |
| EP (1) | EP0135312B1 (de) |
| AT (1) | ATE48945T1 (de) |
| AU (1) | AU578031B2 (de) |
| CA (1) | CA1218931A (de) |
| DE (1) | DE3480828D1 (de) |
| GB (1) | GB8320203D0 (de) |
| HK (1) | HK127693A (de) |
| ZA (1) | ZA845833B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8706052D0 (en) * | 1987-03-13 | 1987-04-15 | Medical Research Int | Therapeutic compositions |
| DE3921062A1 (de) * | 1989-06-23 | 1991-01-03 | Lange Werner | Therapie und prophylaxe von infektionen mit retroviren mit 1-adamantanamin hydrochlorid (amantadin) allein oder in kombination mit anderen antiviralen substanzen |
| DE4014672A1 (de) * | 1990-05-08 | 1991-11-14 | Werner E G Prof Dr Mueller | Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen |
| GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
| WO1993010793A1 (fr) * | 1991-12-03 | 1993-06-10 | Jury Petrovich Vainberg | Agent antiviral |
| IL104283A (en) * | 1992-12-30 | 1996-12-05 | Agis Ind 1983 Ltd | Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate |
| GB9304746D0 (en) * | 1993-03-09 | 1993-04-28 | Scotia Holdings Plc | Treatment of viral infections |
| WO1994020119A1 (en) * | 1993-03-12 | 1994-09-15 | Keele University | Therapeutic compositions containing a lithium compound and silica |
| FR2740342B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques |
| FR2740335B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p |
| FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
| US8236335B2 (en) * | 1999-04-28 | 2012-08-07 | The Regents Of The University Of Michigan | Antimicrobial nanoemulsion compositions and methods |
| US7767216B2 (en) * | 1999-04-28 | 2010-08-03 | The Regents Of The University Of Michigan | Antimicrobial compositions and methods of use |
| US7655252B2 (en) * | 1999-04-28 | 2010-02-02 | The Regents Of The University Of Michigan | Antimicrobial nanoemulsion compositions and methods |
| GB2355192A (en) * | 1999-10-15 | 2001-04-18 | Henderson Morley Res & Dev Ltd | Anti-viral treatment |
| CN1213757C (zh) * | 1999-12-30 | 2005-08-10 | 亨德森莫利研究和开发有限公司 | Dna病毒感染的协同治疗 |
| ES2164018B1 (es) * | 2000-05-26 | 2003-06-16 | Inst De Salud Carlos Iii | Empleo de una sal de litio en la elaboracion de un medicamento para el tratamiento de la infeccion causada por el virus respiratorio sincitial humano (vrdh) |
| EP2152304B1 (de) | 2007-05-02 | 2018-08-22 | The Regents of the University of Michigan | Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür |
| WO2010057197A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA849491A (en) * | 1967-06-05 | 1970-08-18 | Sherwin Lewis | Compositions containing lithium compounds |
| US3639625A (en) * | 1967-07-13 | 1972-02-01 | Lewis Sherwin | Compositions containing lithium succinate |
| FR2244485A1 (en) * | 1973-08-06 | 1975-04-18 | Aries Robert | Lithium dicarboxylic acid salts - in compositions for treatment of psychoses, esp. manic depression |
-
1983
- 1983-07-27 GB GB838320203A patent/GB8320203D0/en active Pending
-
1984
- 1984-07-26 AT AT84305102T patent/ATE48945T1/de not_active IP Right Cessation
- 1984-07-26 DE DE8484305102T patent/DE3480828D1/de not_active Expired - Lifetime
- 1984-07-26 CA CA000459731A patent/CA1218931A/en not_active Expired
- 1984-07-26 AU AU31204/84A patent/AU578031B2/en not_active Ceased
- 1984-07-26 EP EP84305102A patent/EP0135312B1/de not_active Expired
- 1984-07-27 ZA ZA845833A patent/ZA845833B/xx unknown
-
1988
- 1988-02-23 US US07/159,128 patent/US4886670A/en not_active Expired - Fee Related
-
1989
- 1989-10-31 US US07/429,601 patent/US5080909A/en not_active Expired - Fee Related
-
1993
- 1993-11-18 HK HK1276/93A patent/HK127693A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US5080909A (en) | 1992-01-14 |
| ZA845833B (en) | 1985-03-27 |
| CA1218931A (en) | 1987-03-10 |
| US4886670A (en) | 1989-12-12 |
| DE3480828D1 (de) | 1990-02-01 |
| AU3120484A (en) | 1985-09-12 |
| AU578031B2 (en) | 1988-10-13 |
| EP0135312B1 (de) | 1989-12-27 |
| GB8320203D0 (en) | 1983-09-01 |
| EP0135312A3 (en) | 1986-12-30 |
| HK127693A (en) | 1993-11-26 |
| EP0135312A2 (de) | 1985-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3480828D1 (de) | Antivirale zusammensetzungen. | |
| MY102473A (en) | Purine derivates and their pharmaceutical use | |
| IT7819512A0 (it) | Copolieteresterammidi stabili all'idrolisi. | |
| ATE16009T1 (de) | Produktion von 4-chloro-7-(2,3,5-tri-o-benzylbeta-d-arabinofuranosyl)-7h-pyrrolo(2,3-d) pyrimidinderivaten. | |
| GB2103619B (en) | Sulfur-substituted phenoxypyridines | |
| SE415351B (sv) | Sett att framstella 5-amino-1,2,3-tiadiazol | |
| JPS52285A (en) | Preparation of n1 *22tetrahydrofuryl**55fluorouracil | |
| SE428468B (sv) | Sett att framstella 3,3'-triarylmetandikarboxylsyraderivat | |
| GB2022412B (en) | Antiviral compositions | |
| JPS53127834A (en) | Anti-tumor preparation | |
| GB2026031B (en) | Circuit arrangement to increase the life of electrodes used as anodes | |
| SE7809345L (sv) | Sett att framstella 2,5-diketoglukonsyra | |
| JPS5259192A (en) | Preparation of 2,6-bis(diethanolamino)_4,8-dipiperidino-pyrimido 5,4-d pyrimidines | |
| JPS53139657A (en) | Polyolefin resin composition | |
| JPS5325387A (en) | Solar battery watch | |
| JPS5289678A (en) | Preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil | |
| JPS5289679A (en) | Preparation of 5-fluorouracil derivatives | |
| JPS5371086A (en) | Preparation of uracil derivs. | |
| JPS5421252A (en) | Noise suppression circuit | |
| JPS5268190A (en) | Preparation of pyrimidine-type nucleosides | |
| JPS52156597A (en) | Light emitting diode driving circuit | |
| JPS57185204A (en) | Herbicide | |
| JPS52125177A (en) | Preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil | |
| JPS5233683A (en) | Preparation of 1-(2'-tetrahydrofuryl)-5-flurouracil | |
| JPS52139078A (en) | Preparation of uracil derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |